EGFR and neoplasm: Other alterations in genes such as EGFR (mutations or amplification) in H3K27M mutants or EZHIP (overexpression) in H3 wild-type midline tumors have also been identified and contributed to the most recent definition of the DMG-H3K27 tumor subtype.